Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SGLB

Sigma Labs (SGLB) Stock Price, News & Analysis

Sigma Labs logo

About Sigma Labs Stock (NASDAQ:SGLB)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.97
$2.13
52-Week Range
N/A
Volume
84 shs
Average Volume
57,816 shs
Market Capitalization
$11.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SGLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sigma Labs and its competitors with MarketBeat's FREE daily newsletter.

SGLB Stock News Headlines

Metasphere Labs Inc. (LABZ.NE)
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Here's what Wall Street expects from Sigma Labs's earnings report
Sigma Labs earnings preview: what Wall Street is expecting
Sigma Labs
See More Headlines

SGLB Stock Analysis - Frequently Asked Questions

Sigma Labs, Inc. (NASDAQ:SGLB) announced its earnings results on Thursday, October, 21st. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.12. The firm had revenue of $0.70 million for the quarter, compared to analyst estimates of $0.63 million. Sigma Labs had a negative trailing twelve-month return on equity of 65.00% and a negative net margin of 718.15%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sigma Labs investors own include Pfizer (PFE), Ford Motor (F), Avino Silver & Gold Mines (ASM), Intel (INTC), Micron Technology (MU), NIO (NIO) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
10/21/2021
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Miscellaneous Manufacturing Industries
Sub-Industry
N/A
Current Symbol
NASDAQ:SGLB
CIK
788611
Employees
33
Year Founded
2010

Profitability

EPS (Trailing Twelve Months)
($0.86)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.39 million
Net Margins
-718.15%
Pretax Margin
-718.15%
Return on Equity
-65.00%
Return on Assets
-61.17%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
11.69
Quick Ratio
10.82

Sales & Book Value

Annual Sales
$1.65 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.03 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
10,499,000
Free Float
10,054,000
Market Cap
$11.02 million
Optionable
Not Optionable
Beta
1.36

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:SGLB) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners